Elicio Therapeutics Inc. (ELTX) stock news · rev $2.3M
Elicio Therapeutics Inc. (ELTX) is a biotechnology company listed on US.
This ELTX news page leads with what Elicio Therapeutics Inc. filed — not a scraped headline mill.
No cached 8-K sentence for ELTX yet. We will not pad this page with generic market recap.
Latest reported ELTX revenue for 2022-12-31 was $2.3M. Net income was -$38.8M. ELTX currently screens at market cap $132.3M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ELTX stock page; for the tape open the quote page.
ELTX stock news FAQ
What are ELTX's latest revenue and net income?
Latest cached Elicio Therapeutics Inc. (ELTX) revenue for Dec 31, 2022 was $2.3M. Net income was -$38.8M. Statements: https://lician.com/financials/eltx
What is ELTX's market cap?
Elicio Therapeutics Inc. (ELTX) market cap is $132.3M on the latest cached fundamentals snapshot.
What kind of company is ELTX?
Elicio Therapeutics Inc. (ELTX) is a biotechnology company listed on US.
Where is ELTX stock news listed?
Cached stock news for Elicio Therapeutics Inc. (ELTX) is listed at https://lician.com/news/eltx. Filings: https://lician.com/sec/eltx
Not investment advice.